TUESDAY Feb. 26, 2013 — The U.S. Food and Drug Administration has approved a new drug to treat postmenopausal women who experience pain during sex, the agency announced Tuesday. The drug Osphena (ospemifene) mimics the effects of estrogen on vaginal
FDA Approves Kadcyla for Late-Stage Breast Cancer
February 22, 2013 — The U.S. Food and Drug Administration today approved Kadcyla (ado-trastuzumab emtansine), a new therapy for patients with HER2-positive, late-stage (metastatic) breast cancer. HER2 is a protein involved in normal cell growth. It is found in increased